ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tagrisso (Osimertinib) Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-35O10287
Home | Market Reports | Health| Pharmacy
Global Tagrisso Osimertinib Market Research Report 2022
BUY CHAPTERS

Global Tagrisso (Osimertinib) Market Research Report 2025

Code: QYRE-Auto-35O10287
Report
February 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
Incepta Pharmaceuticals Ltd.
Lonza
Everest Pharmaceuticals
Beacon Pharmaceuticals Limited
Drug International Limited

Tagrisso (Osimertinib) Market

The global market for Tagrisso (Osimertinib) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Tagrisso, also known by its generic name Osimertinib, is a medication used to treat certain types of non-small cell lung cancer (NSCLC). It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs), which work by blocking the action of certain proteins involved in the growth and spread of cancer cells. Tagrisso is specifically used for the treatment of NSCLC that has certain mutations in the epidermal growth factor receptor (EGFR) gene.
North American market for Tagrisso (Osimertinib) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tagrisso (Osimertinib) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tagrisso (Osimertinib) include AstraZeneca, Incepta Pharmaceuticals Ltd, Lonza AG, Everest Pharmaceuticals, Beacon Pharmaceuticals Limited, Drug International Limited, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tagrisso (Osimertinib), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tagrisso (Osimertinib).
The Tagrisso (Osimertinib) market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tagrisso (Osimertinib) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tagrisso (Osimertinib) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tagrisso (Osimertinib) Market Report

Report Metric Details
Report Name Tagrisso (Osimertinib) Market
Segment by Type
  • 40 mg
  • 80 mg
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Incepta Pharmaceuticals Ltd, Lonza AG, Everest Pharmaceuticals, Beacon Pharmaceuticals Limited, Drug International Limited
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tagrisso (Osimertinib) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tagrisso (Osimertinib) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Tagrisso (Osimertinib) Market report?

Ans: The main players in the Tagrisso (Osimertinib) Market are AstraZeneca, Incepta Pharmaceuticals Ltd, Lonza AG, Everest Pharmaceuticals, Beacon Pharmaceuticals Limited, Drug International Limited

What are the Application segmentation covered in the Tagrisso (Osimertinib) Market report?

Ans: The Applications covered in the Tagrisso (Osimertinib) Market report are Locally Advanced NSCLC, Metastatic NSCLC, Other

What are the Type segmentation covered in the Tagrisso (Osimertinib) Market report?

Ans: The Types covered in the Tagrisso (Osimertinib) Market report are 40 mg, 80 mg

Recommended Reports

Lung Cancer Treatment

Cancer Diagnostic & Targeting

Oncology Therapeutics

1 Tagrisso (Osimertinib) Market Overview
1.1 Product Definition
1.2 Tagrisso (Osimertinib) by Type
1.2.1 Global Tagrisso (Osimertinib) Market Value Comparison by Type (2024 VS 2031)
1.2.2 40 mg
1.2.3 80 mg
1.3 Tagrisso (Osimertinib) by Application
1.3.1 Global Tagrisso (Osimertinib) Market Value by Application (2024 VS 2031)
1.3.2 Locally Advanced NSCLC
1.3.3 Metastatic NSCLC
1.3.4 Other
1.4 Global Tagrisso (Osimertinib) Market Size Estimates and Forecasts
1.4.1 Global Tagrisso (Osimertinib) Revenue 2020-2031
1.4.2 Global Tagrisso (Osimertinib) Sales 2020-2031
1.4.3 Global Tagrisso (Osimertinib) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tagrisso (Osimertinib) Market Competition by Manufacturers
2.1 Global Tagrisso (Osimertinib) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tagrisso (Osimertinib) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tagrisso (Osimertinib) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tagrisso (Osimertinib), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tagrisso (Osimertinib), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tagrisso (Osimertinib), Product Type & Application
2.7 Global Key Manufacturers of Tagrisso (Osimertinib), Date of Enter into This Industry
2.8 Global Tagrisso (Osimertinib) Market Competitive Situation and Trends
2.8.1 Global Tagrisso (Osimertinib) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tagrisso (Osimertinib) Players Market Share by Revenue
2.8.3 Global Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tagrisso (Osimertinib) Market Scenario by Region
3.1 Global Tagrisso (Osimertinib) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tagrisso (Osimertinib) Sales by Region: 2020-2031
3.2.1 Global Tagrisso (Osimertinib) Sales by Region: 2020-2025
3.2.2 Global Tagrisso (Osimertinib) Sales by Region: 2026-2031
3.3 Global Tagrisso (Osimertinib) Revenue by Region: 2020-2031
3.3.1 Global Tagrisso (Osimertinib) Revenue by Region: 2020-2025
3.3.2 Global Tagrisso (Osimertinib) Revenue by Region: 2026-2031
3.4 North America Tagrisso (Osimertinib) Market Facts & Figures by Country
3.4.1 North America Tagrisso (Osimertinib) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tagrisso (Osimertinib) Sales by Country (2020-2031)
3.4.3 North America Tagrisso (Osimertinib) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tagrisso (Osimertinib) Market Facts & Figures by Country
3.5.1 Europe Tagrisso (Osimertinib) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tagrisso (Osimertinib) Sales by Country (2020-2031)
3.5.3 Europe Tagrisso (Osimertinib) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tagrisso (Osimertinib) Market Facts & Figures by Region
3.6.1 Asia Pacific Tagrisso (Osimertinib) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tagrisso (Osimertinib) Sales by Region (2020-2031)
3.6.3 Asia Pacific Tagrisso (Osimertinib) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tagrisso (Osimertinib) Market Facts & Figures by Country
3.7.1 Latin America Tagrisso (Osimertinib) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tagrisso (Osimertinib) Sales by Country (2020-2031)
3.7.3 Latin America Tagrisso (Osimertinib) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tagrisso (Osimertinib) Market Facts & Figures by Country
3.8.1 Middle East and Africa Tagrisso (Osimertinib) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tagrisso (Osimertinib) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tagrisso (Osimertinib) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Tagrisso (Osimertinib) Sales by Type (2020-2031)
4.1.1 Global Tagrisso (Osimertinib) Sales by Type (2020-2025)
4.1.2 Global Tagrisso (Osimertinib) Sales by Type (2026-2031)
4.1.3 Global Tagrisso (Osimertinib) Sales Market Share by Type (2020-2031)
4.2 Global Tagrisso (Osimertinib) Revenue by Type (2020-2031)
4.2.1 Global Tagrisso (Osimertinib) Revenue by Type (2020-2025)
4.2.2 Global Tagrisso (Osimertinib) Revenue by Type (2026-2031)
4.2.3 Global Tagrisso (Osimertinib) Revenue Market Share by Type (2020-2031)
4.3 Global Tagrisso (Osimertinib) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tagrisso (Osimertinib) Sales by Application (2020-2031)
5.1.1 Global Tagrisso (Osimertinib) Sales by Application (2020-2025)
5.1.2 Global Tagrisso (Osimertinib) Sales by Application (2026-2031)
5.1.3 Global Tagrisso (Osimertinib) Sales Market Share by Application (2020-2031)
5.2 Global Tagrisso (Osimertinib) Revenue by Application (2020-2031)
5.2.1 Global Tagrisso (Osimertinib) Revenue by Application (2020-2025)
5.2.2 Global Tagrisso (Osimertinib) Revenue by Application (2026-2031)
5.2.3 Global Tagrisso (Osimertinib) Revenue Market Share by Application (2020-2031)
5.3 Global Tagrisso (Osimertinib) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Tagrisso (Osimertinib) Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Incepta Pharmaceuticals Ltd
6.2.1 Incepta Pharmaceuticals Ltd Company Information
6.2.2 Incepta Pharmaceuticals Ltd Description and Business Overview
6.2.3 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product Portfolio
6.2.5 Incepta Pharmaceuticals Ltd Recent Developments/Updates
6.3 Lonza AG
6.3.1 Lonza AG Company Information
6.3.2 Lonza AG Description and Business Overview
6.3.3 Lonza AG Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Lonza AG Tagrisso (Osimertinib) Product Portfolio
6.3.5 Lonza AG Recent Developments/Updates
6.4 Everest Pharmaceuticals
6.4.1 Everest Pharmaceuticals Company Information
6.4.2 Everest Pharmaceuticals Description and Business Overview
6.4.3 Everest Pharmaceuticals Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Everest Pharmaceuticals Tagrisso (Osimertinib) Product Portfolio
6.4.5 Everest Pharmaceuticals Recent Developments/Updates
6.5 Beacon Pharmaceuticals Limited
6.5.1 Beacon Pharmaceuticals Limited Company Information
6.5.2 Beacon Pharmaceuticals Limited Description and Business Overview
6.5.3 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product Portfolio
6.5.5 Beacon Pharmaceuticals Limited Recent Developments/Updates
6.6 Drug International Limited
6.6.1 Drug International Limited Company Information
6.6.2 Drug International Limited Description and Business Overview
6.6.3 Drug International Limited Tagrisso (Osimertinib) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Drug International Limited Tagrisso (Osimertinib) Product Portfolio
6.6.5 Drug International Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tagrisso (Osimertinib) Industry Chain Analysis
7.2 Tagrisso (Osimertinib) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tagrisso (Osimertinib) Production Mode & Process Analysis
7.4 Tagrisso (Osimertinib) Sales and Marketing
7.4.1 Tagrisso (Osimertinib) Sales Channels
7.4.2 Tagrisso (Osimertinib) Distributors
7.5 Tagrisso (Osimertinib) Customer Analysis
8 Tagrisso (Osimertinib) Market Dynamics
8.1 Tagrisso (Osimertinib) Industry Trends
8.2 Tagrisso (Osimertinib) Market Drivers
8.3 Tagrisso (Osimertinib) Market Challenges
8.4 Tagrisso (Osimertinib) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
Incepta Pharmaceuticals Ltd.
Lonza
Everest Pharmaceuticals
Beacon Pharmaceuticals Limited
Drug International Limited
List of Tables
 Table 1. Global Tagrisso (Osimertinib) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tagrisso (Osimertinib) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tagrisso (Osimertinib) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tagrisso (Osimertinib) Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Tagrisso (Osimertinib) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tagrisso (Osimertinib) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tagrisso (Osimertinib) Average Price (US$/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tagrisso (Osimertinib), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tagrisso (Osimertinib), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tagrisso (Osimertinib), Product Type & Application
 Table 12. Global Key Manufacturers of Tagrisso (Osimertinib), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tagrisso (Osimertinib) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tagrisso (Osimertinib) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tagrisso (Osimertinib) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tagrisso (Osimertinib) Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Tagrisso (Osimertinib) Sales Market Share by Region (2020-2025)
 Table 19. Global Tagrisso (Osimertinib) Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Tagrisso (Osimertinib) Sales Market Share by Region (2026-2031)
 Table 21. Global Tagrisso (Osimertinib) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tagrisso (Osimertinib) Revenue Market Share by Region (2020-2025)
 Table 23. Global Tagrisso (Osimertinib) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tagrisso (Osimertinib) Revenue Market Share by Region (2026-2031)
 Table 25. North America Tagrisso (Osimertinib) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tagrisso (Osimertinib) Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Tagrisso (Osimertinib) Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Tagrisso (Osimertinib) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tagrisso (Osimertinib) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tagrisso (Osimertinib) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tagrisso (Osimertinib) Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Tagrisso (Osimertinib) Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Tagrisso (Osimertinib) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tagrisso (Osimertinib) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tagrisso (Osimertinib) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tagrisso (Osimertinib) Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Tagrisso (Osimertinib) Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Tagrisso (Osimertinib) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tagrisso (Osimertinib) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tagrisso (Osimertinib) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tagrisso (Osimertinib) Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Tagrisso (Osimertinib) Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Tagrisso (Osimertinib) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tagrisso (Osimertinib) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tagrisso (Osimertinib) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tagrisso (Osimertinib) Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Tagrisso (Osimertinib) Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Tagrisso (Osimertinib) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tagrisso (Osimertinib) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tagrisso (Osimertinib) Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Tagrisso (Osimertinib) Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Tagrisso (Osimertinib) Sales Market Share by Type (2020-2025)
 Table 53. Global Tagrisso (Osimertinib) Sales Market Share by Type (2026-2031)
 Table 54. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tagrisso (Osimertinib) Revenue Market Share by Type (2020-2025)
 Table 57. Global Tagrisso (Osimertinib) Revenue Market Share by Type (2026-2031)
 Table 58. Global Tagrisso (Osimertinib) Price (US$/Pcs) by Type (2020-2025)
 Table 59. Global Tagrisso (Osimertinib) Price (US$/Pcs) by Type (2026-2031)
 Table 60. Global Tagrisso (Osimertinib) Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Tagrisso (Osimertinib) Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Tagrisso (Osimertinib) Sales Market Share by Application (2020-2025)
 Table 63. Global Tagrisso (Osimertinib) Sales Market Share by Application (2026-2031)
 Table 64. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tagrisso (Osimertinib) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tagrisso (Osimertinib) Revenue Market Share by Application (2020-2025)
 Table 67. Global Tagrisso (Osimertinib) Revenue Market Share by Application (2026-2031)
 Table 68. Global Tagrisso (Osimertinib) Price (US$/Pcs) by Application (2020-2025)
 Table 69. Global Tagrisso (Osimertinib) Price (US$/Pcs) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Tagrisso (Osimertinib) Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Incepta Pharmaceuticals Ltd Company Information
 Table 76. Incepta Pharmaceuticals Ltd Description and Business Overview
 Table 77. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 78. Incepta Pharmaceuticals Ltd Tagrisso (Osimertinib) Product
 Table 79. Incepta Pharmaceuticals Ltd Recent Developments/Updates
 Table 80. Lonza AG Company Information
 Table 81. Lonza AG Description and Business Overview
 Table 82. Lonza AG Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 83. Lonza AG Tagrisso (Osimertinib) Product
 Table 84. Lonza AG Recent Developments/Updates
 Table 85. Everest Pharmaceuticals Company Information
 Table 86. Everest Pharmaceuticals Description and Business Overview
 Table 87. Everest Pharmaceuticals Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 88. Everest Pharmaceuticals Tagrisso (Osimertinib) Product
 Table 89. Everest Pharmaceuticals Recent Developments/Updates
 Table 90. Beacon Pharmaceuticals Limited Company Information
 Table 91. Beacon Pharmaceuticals Limited Description and Business Overview
 Table 92. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 93. Beacon Pharmaceuticals Limited Tagrisso (Osimertinib) Product
 Table 94. Beacon Pharmaceuticals Limited Recent Developments/Updates
 Table 95. Drug International Limited Company Information
 Table 96. Drug International Limited Description and Business Overview
 Table 97. Drug International Limited Tagrisso (Osimertinib) Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2020-2025)
 Table 98. Drug International Limited Tagrisso (Osimertinib) Product
 Table 99. Drug International Limited Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Tagrisso (Osimertinib) Distributors List
 Table 103. Tagrisso (Osimertinib) Customers List
 Table 104. Tagrisso (Osimertinib) Market Trends
 Table 105. Tagrisso (Osimertinib) Market Drivers
 Table 106. Tagrisso (Osimertinib) Market Challenges
 Table 107. Tagrisso (Osimertinib) Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tagrisso (Osimertinib)
 Figure 2. Global Tagrisso (Osimertinib) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tagrisso (Osimertinib) Market Share by Type: 2024 & 2031
 Figure 4. 40 mg Product Picture
 Figure 5. 80 mg Product Picture
 Figure 6. Global Tagrisso (Osimertinib) Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Tagrisso (Osimertinib) Market Share by Application: 2024 & 2031
 Figure 8. Locally Advanced NSCLC
 Figure 9. Metastatic NSCLC
 Figure 10. Other
 Figure 11. Global Tagrisso (Osimertinib) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Tagrisso (Osimertinib) Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Tagrisso (Osimertinib) Sales (2020-2031) & (K Pcs)
 Figure 14. Global Tagrisso (Osimertinib) Average Price (US$/Pcs) & (2020-2031)
 Figure 15. Tagrisso (Osimertinib) Report Years Considered
 Figure 16. Tagrisso (Osimertinib) Sales Share by Manufacturers in 2024
 Figure 17. Global Tagrisso (Osimertinib) Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Tagrisso (Osimertinib) Players: Market Share by Revenue in Tagrisso (Osimertinib) in 2024
 Figure 19. Tagrisso (Osimertinib) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Tagrisso (Osimertinib) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Tagrisso (Osimertinib) Sales Market Share by Country (2020-2031)
 Figure 22. North America Tagrisso (Osimertinib) Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Tagrisso (Osimertinib) Sales Market Share by Country (2020-2031)
 Figure 26. Europe Tagrisso (Osimertinib) Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Tagrisso (Osimertinib) Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Tagrisso (Osimertinib) Revenue Market Share by Region (2020-2031)
 Figure 34. China Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Tagrisso (Osimertinib) Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Tagrisso (Osimertinib) Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Tagrisso (Osimertinib) Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Tagrisso (Osimertinib) Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Tagrisso (Osimertinib) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Tagrisso (Osimertinib) by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Tagrisso (Osimertinib) by Type (2020-2031)
 Figure 56. Global Tagrisso (Osimertinib) Price (US$/Pcs) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Tagrisso (Osimertinib) by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Tagrisso (Osimertinib) by Application (2020-2031)
 Figure 59. Global Tagrisso (Osimertinib) Price (US$/Pcs) by Application (2020-2031)
 Figure 60. Tagrisso (Osimertinib) Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Osimertinib Market Research Report 2024
Global Trametinib Market Research Report 2025
Global Ceritinib Market Research Report 2024
Global Axitinib Market Research Report 2025
Global Olaparib Market Research Report 2024
Global Crizotinib Market Research Report 2024
Global Tucatinib Market Research Report 2025
Global Sunitinib Malate Market Research Report 2025
Global Nitisinone Drug Market Research Report 2024
Global Sonidegib Market Research Report 2025
Global Nesiritide Market Research Report 2024
Global Erlotinib Market Research Report 2024
Global Nintedanib Market Research Report 2024
Global Sunitinib API Market Research Report 2025
Osimertinib Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Osimertinib Generics Market Research Report 2024
Global Gefitinib Market Research Report 2024
Global Regorafenib Market Research Report 2024
Global Tofacitinib Market Research Report 2024
Global Spiromesifen Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions